Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Aptevo Therapeutics (APVO) Institutional Ownership

Aptevo Therapeutics logo
$5.04 +0.49 (+10.77%)
Closing price 04:00 PM Eastern
Extended Trading
$4.92 -0.12 (-2.46%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)

Current
Institutional Ownership
Percentage
8.06%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$1.55M
Number of
Institutional Sellers
(last 12 months)
0
Get APVO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

APVO Institutional Buying and Selling by Quarter

Aptevo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2025 Virtu Financial LLC38,282$56K0.0%N/A1.164%
8/15/2025 Birchview Capital LP10,000$30K0.0%N/A1.316%
2/11/2025Virtu Financial LLC21,627$93K0.0%-48.5%4.241%
8/15/2024Armistice Capital LLC749,234$229K0.0%N/A18.359%
11/15/2023Sabby Management LLC1,334,169$440K0.3%N/A11.581%
11/15/2023Armistice Capital LLC1,235,000$408K0.0%N/A10.717%
2/1/2023Bank of Montreal Can10,000$61K0.0%N/A0.196%
11/15/2022Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627%
11/7/2022Virtu Financial LLC28,421$86K0.0%+122.6%0.558%


APVO Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Armistice Capital LLC ($229K), and Virtu Financial LLC ($56K), Birchview Capital LP ($30K).Learn more on Aptevo Therapeutics' institutional investors.

8.06% of Aptevo Therapeutics' stock is owned by institutional investors. Learn more on APVO's institutional investor holdings.

The following institutional investors have purchased Aptevo Therapeutics' stock in the last 24 months: Armistice Capital LLC ($749.23K), Virtu Financial LLC ($38.28K), and Birchview Capital LP ($10K).

Institutional investors have bought a total of 48,282 shares in the last 24 months. This purchase volume represents approximately $1.55M in transactions.



This page (NASDAQ:APVO) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners